Mounjaro 12.5 mg/0.5 ml

Mounjaro 12.5 mg/0.5 ml is an FDA-approved once-weekly injection to decrease blood sugar (blood glucose) in adults with type 2 diabetes. It should be used together with diet and exercise. Mounjaro 12.5 mg/0.5 ml pen has also been shown in clinical trials to be beneficial for weight loss; however, it is currently not an FDA-approved weight loss drug.

Diabetes is a long-term condition when your blood sugars (HbA1c) become too high because the body does not produce or use insulin usually. Over time, high blood sugar can cause serious health problems, including heart disease, vision loss, and kidney disease.

Mounjaro works to reduce blood sugar levels by increasing your insulin production and also lowering the amount of sugar your liver makes. It also slows the rate of food passing through your body, making you feel full longer.

Mounjaro (Tirzepatide) is the first dual GIP/GLP-1 receptor agonist, which means it works on the glucose-dependent insulinotropic polypeptide (GIP) receptors and the glucagon-like peptide-1 (GLP-1) receptors.

Mounjaro can be used as a single therapy or in combination with other diabetes medicines, such as metformin, sulfonylureas, or SGLT2 inhibitors.

It is unknown if this medicine can be used in people with pancreatitis.

Mounjaro 12.5 mg/0.5 ml is not for use in people with type 1 diabetes.

Is Mounjaro used for weight loss?
Mounjaro has also been shown to help overweight patients lose weight. It is currently in Phase 3 clinical trials for weight loss in adults who are overweight, obese, or have weight-related health issues. Mounjaro has received the FDA Fast Track designation to speed up its path for FDA submission for treating adults with obesity or overweight with weight-related health conditions.

In the SURMOUNT-1 clinical trial, the average weight loss after 72 weeks was 15% for the 5 mg dose, 19.5% for the 10 mg dose, and 20.9% for the 15 mg dose.

Mounjaro 12.5 mg/0.5 ml is not FDA-approved weight loss medication.

Important Information:
Mounjaro may cause thyroid C-cell tumours. Tell your doctor if you have a personal or family history of thyroid cancer or a condition called Multiple Endocrine Neoplasia (MEN) syndrome (a syndrome that causes tumours to develop on endocrine glands). If you experience any of the following symptoms, call your doctor immediately: lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.

Keep all appointments with your doctor and the laboratory. Your doctor may order specific tests to check your body’s response to this medicine.

Before Using Mounjaro:
Tell your doctor and pharmacist if you are allergic to Mounjaro 12.5 mg/0.5 ml, other medications, or ingredients in this injection. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

Tell your doctor if you have or have ever had pancreas or kidney disease, stomach problems such as difficulty digesting food, or a history of diabetic retinopathy.

Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking this medicine, call your doctor.

How Should I Use Mounjaro?
Mounjaro 12.5 mg/0.5 ml pen comes as a solution (liquid) in a pre-filled pen to be injected subcutaneously (under the skin). It is usually given once a week with or without meals at any time of the day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use this medicine exactly as directed. Please do not take more or less of it or more often than your doctor prescribes.

Your doctor will probably start you on a low dose and gradually increase your dose, not more than once every 4 weeks.

You may change the day of the week you inject this medicine as long as at least 3 days have passed between doses.

You may administer insulin in the same area as Mounjaro 12.5 mg/0.5 ml, but they should not be given right next to each other. Also, you should not mix Mounjaro and insulin in the same injection.

Mounjaro controls type 2 diabetes but does not cure it. It may take 4 weeks or longer before you feel the full benefit of this medicine. Continue to take this medicine even if you feel well. Do not stop taking this medicine without talking to your doctor.

Mounjaro can be injected into the abdomen, thigh, or upper arm. With each dose, rotate the injection sites.

What Should I Do If I Miss a Dose?
Take the missed dose as soon as you remember it within 4 days after the missed dose. However, if more than 4 days have passed, skip the missed dose and continue your regular dosing schedule. Do not inject two doses within 3 days of each other.

What Are the Side Effects of Mounjaro 12.5 mg/0.5 ml?
Mounjaro may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

nausea
diarrhoea
decreased appetite
vomiting
constipation
upset stomach
Some side effects can be severe. If you experience any of these symptoms or those listed in the Important Information section, stop taking this medicine and call your doctor immediately:

Stomach pain that will not go away (and may radiate to the back) with or without vomiting
Mounjaro may cause hypoglycemia (low blood sugar). Signs and symptoms of low blood sugar may include dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heart rate, and feeling jittery.

This medicine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication. If you experience a profound side effect, you or your doctor may send a report to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program online or by phone (1-800-332-1088).

Interactions:
Tell your doctor and pharmacist what prescription and non-prescription medications, vitamins, nutritional supplements, and herbal products you plan to take. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

Birth control pills may not work as well while receiving this medicine. Your doctor may suggest you use another form of birth control for 4 weeks after starting Mounjaro and for 4 weeks after each dose change.

Taking Mounjaro 12.5 mg/0.5 ml with other diabetes medicines, such as insulin or sulfonylureas, may increase your risk of hypoglycemia. Talk to your doctor and pharmacist about managing low blood sugar.

This list is not complete. Many other drugs, including prescription and over-the-counter medicines, vitamins, and herbal products, may interact with Mounjaro 12.5 mg 0.5 ml. To check for interactions with this medicine, click the link below.

Storage:
Mounjaro 12.5 mg 0.5 ml should be stored in the refrigerator between 36°F and 46°F (2°C and 8°C). Please keep it in the original carton until used to protect it from light. Single-dose pens can be stored at room temperature for 21 days if needed. Store your medication only as directed, and make sure you understand how to store it correctly.

What Are the Ingredients in Mounjaro?
Active ingredient: tirzepatide
The inactive ingredients are sodium chloride, sodium phosphate, dibasic heptahydrate, and water for injection. Hydrochloric acid and/or sodium hydroxide solutions may have been added to adjust the pH. buy Mounjaro 12.5 mg/0.5 ml online